US Broker Ratings

ImmunityBio, Inc. (IBRX): An Investor Outlook on a Biotech Stock with 351% Potential Upside

ImmunityBio, Inc. (NASDAQ: IBRX), a prominent player in the biotechnology sector, stands out with an impressive potential upside of 351.33% according to current analyst ratings. The company, based in San..

Denali Therapeutics (DNLI) Stock Analysis: Potential 106.6% Upside Amid Biotech Innovations

Denali Therapeutics Inc. (NASDAQ: DNLI) is capturing attention within the biotechnology sector, primarily due to its promising drug pipeline and the potential for significant stock price appreciation. With a market..

Addus HomeCare Corporation (ADUS) Stock Analysis: Exploring a 19.72% Potential Upside with Strong Buy Ratings

Addus HomeCare Corporation (NASDAQ: ADUS) is making waves in the healthcare sector, particularly within the Medical Care Facilities industry. With a market cap of $2.19 billion, Addus is a notable..

Veracyte, Inc. (VCYT) Stock Analysis: Examining a 12.76% Upside Potential in the Healthcare Sector

Veracyte, Inc. (NASDAQ: VCYT), a key player in the diagnostics and research industry, is garnering attention from investors with its promising growth potential and a notable 12.76% upside based on..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Potential 76% Upside Ignites Investor Interest

Amicus Therapeutics, Inc. (NASDAQ: FOLD), a key player in the biotechnology sector, is capturing investor attention with a compelling potential upside of 76.07% based on its current price and analyst..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating Challenges with Diverse Rare Disease Portfolio

PTC Therapeutics, Inc. (PTCT), a pioneering player in the biotechnology sector, is known for its dedicated focus on the discovery, development, and commercialization of treatments for rare disorders. Headquartered in..

ACADIA Pharmaceuticals Inc. (ACAD): A Biotech Powerhouse with a 29.86% Potential Upside

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biotechnology sector, continues to capture investor attention with its robust focus on central nervous system (CNS) disorders and rare diseases...

Viking Therapeutics, Inc. (VKTX)

⚠️ No article content returned.

..

Metsera, Inc. (MTSR) Stock Analysis: Understanding Its 6.14% Potential Downside Amidst Biotech Innovation

Metsera, Inc. (MTSR) is a burgeoning player in the healthcare sector, specifically within the biotechnology industry. Established in 2022 and headquartered in New York, this clinical-stage company is at the..

LivaNova PLC (LIVN) Stock Analysis: Navigating a 23.62% Potential Upside in the Healthcare Sector

LivaNova PLC (NASDAQ: LIVN) is emerging as a company of interest for investors in the healthcare sector, particularly in the medical devices industry. Based in the United Kingdom, LivaNova specializes..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a 58.3% Upside Potential in the Healthcare Sector

Perrigo Company plc (NYSE: PRGO), a key player in the healthcare sector focusing on over-the-counter solutions, is capturing the attention of investors with a notable potential upside of 58.3%. Headquartered..

Privia Health Group, Inc. (PRVA) Stock Analysis: Unveiling a 22.51% Potential Upside in the Healthcare Sector

Privia Health Group, Inc. (NASDAQ: PRVA) is capturing investors’ attention with its robust growth trajectory, particularly highlighted by a potential upside of 22.51% based on the average analyst target price..

DENTSPLY SIRONA Inc. (XRAY): Investor Outlook with a Promising 27.49% Potential Upside

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $2.5 billion, this..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Unveiling a 33.86% Potential Upside in Gene Editing Innovation

CRISPR Therapeutics AG (NASDAQ: CRSP) stands at the forefront of the biotechnology sector with its groundbreaking CRISPR/Cas9 gene-editing platform, poised to transform the treatment landscape for several serious human diseases...

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring a Potential 156.50% Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a notable player in the biotechnology sector, has captured investor attention with its focus on developing innovative therapies for rare and ultra-rare genetic diseases. Headquartered..

PROCEPT BioRobotics (PRCT) Stock Analysis: A 76% Potential Upside Awaits Investors

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is carving out a niche in the medical devices sector, specifically within the transformative space of surgical robotics for urology. Headquartered in San Jose, California,..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 42.3% Potential Upside with Strong Buy Ratings

ICU Medical, Inc. (NASDAQ: ICUI), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, offers a fascinating investment opportunity characterized by a compelling 42.3%..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Strong Revenue Growth Amidst Clinical Trial Progress

Investors eyeing the biotechnology sector should consider Avidity Biosciences, Inc. (NASDAQ: RNA), a trailblazer in RNA therapeutics with a market capitalization of $10.26 billion. This San Diego-based company stands at..

Glaukos Corporation (GKOS) Stock Analysis: Uncovering a 35.69% Potential Upside in the Medical Device Sector

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, is capturing investor attention with a significant potential upside of 35.69% based on its average target price. Specializing in..

Option Care Health, Inc. (OPCH) Stock Analysis: Unlocking a 36% Upside Potential for Investors

Option Care Health, Inc. (NASDAQ: OPCH), a key player in the healthcare sector, specifically within the medical care facilities industry, is currently capturing the attention of investors with its promising..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds